Targeting MC1R in metastatic melanoma

Targeting MC1R in metastatic melanoma

In 1960, scientists described the “Philadelphia chromosome” that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change. It was the dawn of...